在印度及时启动癌症治疗的机会:范围,决定因素和趋势
Pritam Halder1, Jyoti Dixit1, Nidhi Gupta2
1Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
The Lancet regional health. Southeast Asia
|January 13, 2025
概括
由于政府医疗保险,特别是Pradhan Mantri Jan Arogya Yojana (PMJAY),印度的延迟癌症治疗启动减少了. 这改善了癌症患者及时获得护理的机会,特别是那些被纳入该计划的人.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 癌症患者的治疗延迟与晚期,不良结果和死亡率增加有关.
- 导致这些延迟的因素需要进行严格的评估.
- 了解延迟对于改善印度的癌症护理服务至关重要.
研究的目的:
- 在印度癌症患者中确定延迟治疗开始时间 (TTI).
- 为了确定延迟TTI的决定因素.
- 评估延迟TTI的趋势和医疗保险的影响.
主要方法:
- 分析了印度六个州6695名癌症患者的数据.
- 为确定因素计算中位数TTI和多变量逻辑回归.
- 考克斯比例危险模型评估政府资助的医疗保险 (PMJAY) 的影响.
主要成果:
- 平均TTI为20天;头癌和放射治疗的中位数更高.
- 年轻,受过教育的男性患者的延迟TTI的几率较低.
- 加入PMJAY显著增加了及时开始治疗的比例 (90%与未参加PMJAY的33%相比).
结论:
- 像PMJAY这样的政府资助的健康保险计划对印度及时获得癌症治疗有积极的影响.
- 建议包括扩大PMJAY癌症套餐和改进查计划.
- 解决财务限制和诊断延迟对于减少TTI至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


